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IDENTIFICATION OF A BRAZIL-NUT ALLERGEN IN TRANSGENIC SOYBEANS
JULIE A. NORDLEE, M.S., STEVE L. TAYLOR, PH.D., JEFFREY A. TOWNSEND, B.S., LAURIE A. THOMAS, B.S.,
AND R OBERT K. B USH , M.D.
Abstract Background. The nutritional quality of soybeans (Glycine max ) is compromised by a relative deﬁciency of methionine in the protein fraction of the seeds.
To improve the nutritional quality, methionine-rich 2S albumin from the Brazil nut (Bertholletia excelsa) has been
introduced into transgenic soybeans. Since the Brazil nut
is a known allergenic food, we assessed the allergenicity
of the 2S albumin.
Methods. The ability of proteins in transgenic and nontransgenic soybeans, Brazil nuts, and puriﬁed 2S albumin
to bind to IgE in serum from subjects allergic to Brazil
nuts was determined by radioallergosorbent tests (four
subjects) and sodium dodecyl sulfate–polyacrylamidegel electrophoresis (nine subjects) with immunoblotting
and autoradiography. Three subjects also underwent
skin-prick testing with extracts of soybean, transgenic
soybean, and Brazil nut.

Results. On radioallergosorbent testing of pooled serum from four subjects allergic to Brazil nuts, protein extracts of transgenic soybean inhibited binding of IgE to
Brazil-nut proteins. On immunoblotting, serum IgE from
eight of nine subjects bound to puriﬁed 2S albumin from
the Brazil nut and to proteins of similar molecular weight
in the Brazil nut and the transgenic soybean. On skinprick testing, three subjects had positive reactions to extracts of Brazil nut and transgenic soybean and negative
reactions to soybean extract.
Conclusions. The 2S albumin is probably a major Brazil-nut allergen, and the transgenic soybeans analyzed in
this study contain this protein. Our study shows that an allergen from a food known to be allergenic can be transferred into another food by genetic engineering. (N Engl
J Med 1996;334:688-92.)

A

versely affecting agronomic performance. The 2S albumin
from the seeds of the Brazil nut (Bertholletia excelsa) is
ideal for this purpose because it is composed of 18 percent and 8 percent, respectively, of the sulfur amino acids
methionine and cysteine.8 The 2S albumin gene from the
Brazil nut has been introduced into soybeans,9 tobacco,
oilseed rape (Brassica napus), the legume Vicia narbonensis, and beans (Phaseolus vulgaris).10-14
Our objective was to determine whether the 2S albumin from the Brazil nut as expressed in transgenic soybeans was able to bind IgE from people who are allergic
to Brazil nuts. Proteins that bind IgE from people with
allergies are likely to be allergens, since the mechanism
of immediate hypersensitivity is the cross-linking of speciﬁc proteins and speciﬁc IgE on the surface of sensitized mast cells, causing them to degranulate and release histamine and other mediators of allergic disease.

LLERGIES to nuts are among the most common
food allergies,1 and allergies to the Brazil nut are
well documented.2 Concern has been expressed about
the introduction of allergenic proteins into food plants
by genetic engineering.3-5 The Food and Drug Administration (FDA) has directed developers of new plant varieties to consider the allergenic potential of donor organisms in assessing the safety of foods derived from
genetically engineered plants.6 If there is insufﬁcient information to demonstrate that the introduced protein
could not cause allergic reactions in a susceptible population, then the food would require a label to alert consumers to this fact.
The nutritional quality of legumes, including soybeans
(Glycine max), for both humans and animals is compromised by a deﬁciency of methionine in the protein fraction of the seeds.7 As a result, diets for domestic animals
that are based on soybean meal must be fortiﬁed with
methionine or protein sources of this essential amino
acid. For the same reason, human vegetarians must carefully balance their diets to ensure an adequate intake of
methionine. There have been many attempts to manipulate the balance of essential amino acids in important
crops by traditional methods of plant breeding, but improvements in nutritional quality have often come at the
expense of agronomic properties such as yield or grain
quality. The introduction of genes encoding sulfur-rich
proteins from other plants into soybeans through recombinant-DNA techniques is a promising strategy for improving the nutritional quality of soybeans without adFrom the Department of Food Science and Technology, University of Nebraska, Lincoln (J.A.N., S.L.T.); Research and Product Development, Pioneer HiBred International, Johnston, Iowa (J.A.T., L.A.T.); and William S. Middleton
Memorial Veterans Affairs Hospital and the Department of Medicine and Food
Research Institute, University of Wisconsin–Madison, Madison (R.K.B.). Address reprint requests to Ms. Nordlee at the Department of Food Science and
Technology, University of Nebraska, Lincoln, NE 68583-0919.
Supported by a grant from Pioneer Hi-Bred International, Inc.

1996, Massachusetts Medical Society.

METHODS
Subjects
For radioallergosorbent assays, a serum was pooled from four
subjects with a history of allergic reactions to Brazil nuts that included
oropharyngeal swelling and itching, facial swelling, laryngeal edema,
and bronchospasm with wheezing. All four had positive skin-prick
tests in response to extracts of Brazil nut and positive radioallergosorbent tests, with binding to Brazil-nut protein in the solid phase that
was 9 to 38 times greater than binding with control serum from
subjects with no history of food allergies. For experiments using sodium dodecyl sulfate–polyacrylamide-gel electrophoresis (SDS-PAGE),
serum was obtained from ﬁve additional subjects who either indicated
that they had similar symptoms or reported a history of avoiding all
nuts. These ﬁve also had positive skin-prick tests and positive radioallergosorbent tests, with binding to Brazil-nut protein in the solid
phase that was 4 to 64 times greater than binding with control serum
from subjects with no history of food allergies. As a control, serum was
pooled from eight subjects without food allergies. Skin-prick tests with
transgenic material were performed on three subjects with histories of
sensitivity to Brazil nuts and no history of sensitivity to soybeans and
three subjects (one with atopy) with no history of sensitivity to Brazil
nuts or soybeans. All subjects gave informed consent as stipulated by
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the University of Nebraska or the University of Wisconsin institutional review board or by Plasma Labs, International (Everett, Wash.).
Radioallergosorbent Assay
Transgenic and nontransgenic soybeans were obtained from Pioneer Hi-Bred International ( Johnston, Iowa). Raw Brazil nuts were
obtained from Open Harvest Grocery (Lincoln, Nebr.). The Brazil
nuts, transgenic soybeans, and nontransgenic soybeans were defatted
with acetone and ethyl ether.15 Extracts were prepared (1:10 wt/vol)
with 0.01 M potassium phosphate–buffered saline, pH 7.4, containing
0.02 percent sodium azide and stirred at room temperature for two
hours. The extracts were clariﬁed by ultracentrifugation for one hour
at 82,000g. The protein content of the extracts was determined by
the Lowry–Folin method.16 Brazil-nut protein in the solid phase was
prepared according to the method of Adolphson et al.17 with microcrystalline cellulose and 10 mg of protein from defatted Brazil-nut
extract.
For the radioallergosorbent assay,17 serial dilutions of Brazil-nut
and soybean extracts were prepared with potassium phosphate–buffered saline containing 0.02 percent sodium azide as the diluent and
incubated overnight with Brazil-nut protein in the solid phase and
pooled serum from four subjects allergic to Brazil nuts. The solid
phase was then washed and incubated overnight with antihuman IgE
labeled with iodine-125 (Pharmacia and Upjohn, Diagnostics Division, Columbus, Ohio). Excess labeled antibody was removed by washing, and the radioactivity of the solid phase was measured with a sodium iodide scintillation detector. The percent inhibition of IgE binding
was calculated with the use of values from samples without inhibitor
protein as a measure of maximal binding. For the radioallergosorbent test,17 serum samples were allowed to react directly with the solid
phase without inhibitor protein, and bound IgE was measured as described above. Scores for the radioallergosorbent test were calculated
as a multiple of the score obtained with pooled serum from subjects
without food allergies.

(0.9 percent sodium chloride, 0.03 percent albumin, and 0.04 percent
phenol; Miles Laboratories, Spokane, Wash.).
Skin-prick testing was performed according to the method of Norman.22 A histamine base solution (1.8 mg per milliliter and 50 percent
glycerol wt/vol; Allermed, San Diego, Calif.) and saline diluent were
used as positive and negative controls, respectively. Titration was conducted starting with the most dilute extracts (1:1,000,000) and progressing through serial dilutions until a positive response (3-mm wheal)
was observed in subjects allergic to Brazil nuts. Subjects acting as negative controls underwent skin-prick testing with full-strength extracts
and negative- and positive-control solutions as described above. The
diameter of the wheal-and-ﬂare response was measured 10 minutes after the skin was pricked. The subjects were asked to refrain from taking antihistamines or other medications that could interfere with skintest responses for a minimum of 48 hours before testing.

RESULTS
An extract of transgenic soybean competed effectively with Brazil-nut proteins that were bound to solidphase, microcrystalline cellulose for binding to IgE from
the serum of subjects allergic to Brazil nuts (Fig. 1). The
degree of inhibition observed with the extract of transgenic soybean was similar to that observed with an extract of raw Brazil nut (Fig. 1). No inhibition was encountered with an extract from nontransgenic soybean
that has the same genetic background as the transgenic
plant and similar levels of protein. This result indicates
that the inhibition by the transgenic-soybean extract
was not due to normal soybean proteins or to the nonspeciﬁc binding of 125I-labeled antihuman IgE to soy-

Electrophoresis and Immunoblotting

Skin-Prick Testing with Transgenic Material
Extracts for skin-prick (epicutaneous) testing were prepared from
Brazil nuts, transgenic soybeans, and nontransgenic soybeans obtained from the sources described above. These materials were not
defatted. They were prepared (1:10 wt/vol) with 0.01 M phosphatebuffered saline, pH 7.4, and rocked overnight at 4°C. The extracts
were clariﬁed by ultracentrifugation at 82,000g for one hour and ﬁltered through a series of 0.45-mm and 0.2-mm sterile ﬁlters. The ﬁltrates were collected in sterile vials containing an equal volume of
sterile glycerol, mixed, and stored at 4°C until use. Immediately
before use, serial dilutions of sterile extracts (1:100 to 1:1,000,000
vol/vol) as well as a 1:50 dilution were prepared with a saline diluent

100
90

Inhibition of IgE Binding (%)

Extracts of Brazil nut, transgenic soybean, and nontransgenic soybean were prepared as described above, except that the pH of potassium phosphate–buffered saline containing 0.02 percent sodium azide
was 7.2 and single soybean seeds were used for extraction. The Brazil
nuts and soybeans were not defatted. The puriﬁed 2S albumin from
the Brazil nut18 was diluted in potassium phosphate–buffered saline
containing 0.02 percent sodium azide, pH 7.2. Proteins from these extracts and the 2S albumin were separated by SDS-PAGE with minigels
with gradients of 10 to 20 percent (Bio-Rad Laboratories, Hercules,
Calif.). The wells were loaded with 15 mg of protein from Brazil-nut
and soybean extracts and 3.7 mg of 2S albumin. The proteins were
transferred from gels to nitrocellulose by electroblotting as described
by Towbin et al.19 Nitrocellulose blots were incubated with control serum or individual serum samples from nine subjects allergic to Brazil
nuts. IgE binding was detected by autoradiography after incubation of
the washed blots with 125I-labeled antihuman IgE.20 Alternatively, gels
obtained with SDS-PAGE were stained with Coomassie blue to visualize the proteins.21 a-Lactalbumin (14.4 kd), soybean trypsin inhibitor (20.1 kd), carbonic anhydrase (30 kd), ovalbumin (43 kd), bovine
serum albumin (67 kd), and rabbit-muscle phosphorylase b (94 kd)
served as molecular-weight markers.
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Figure 1. Results of Radioallergosorbent Assays with Extracts
of Nontransgenic Soybean (), Transgenic Soybean (), and
Brazil Nut ().
The logarithm of the number of nanograms of total protein in each
dilution of extract was plotted against the percent inhibition of IgE
binding as calculated by the following formula: (counts without inhibitor protein  counts with inhibitor protein)  100  counts without inhibitor protein. The slope of the inhibition curve for the Brazil-nut extract was 40.8, whereas the slope of the curve for
the transgenic-soybean extract was 39.4.
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Figure 2. Results of SDS–PAGE and Autoradiography.
In Panel A, SDS–PAGE gels (gradient, 10 to 20 percent) were stained with Coomassie blue. Lane 1 shows the molecular-weight
standards; lane 2, nontransgenic-soybean extract; lane 3, transgenic-soybean extract; lane 4, Brazil-nut extract; and lane 5, puriﬁed
2S albumin from the Brazil nut. Panels B, C, and D show autoradiographic results of IgE binding. In Panel B, IgE in serum from a
subject allergic to Brazil nuts bound to the 9-kd 2S albumin Brazil-nut protein (lane 4) and proteins of similar molecular weights in
extracts from Brazil nut (lane 3) and transgenic soybean (lane 2), but did not react with an extract of nontransgenic soybean (lane
1). In Panel C, IgE in serum from a subject allergic to Brazil nuts bound to the 9-kd 2S albumin in Brazil-nut extract (lane 2) and to
the 9-kd 2S albumin and 12-kd processed intermediate in transgenic soybean (lane 1). In Panel D, IgE in serum from a subject allergic
to Brazil nuts bound to a 42-kd protein in Brazil-nut extract (lane 1) but did not bind detectably to the 2S albumin in transgenicsoybean extract.

bean extract. The parallel inhibition slopes obtained
with extracts of transgenic soybean and Brazil nut indicate considerable similarity between the IgE-binding
epitopes in these two extracts.
IgE from eight of the nine subjects allergic to Brazil
nuts bound to puriﬁed 2S albumin from the Brazil nut
(molecular weight, 9000)18 and to a 9-kd protein in an
extract of whole Brazil nut (Fig. 2A and 2B). IgE from
seven of the nine subjects allergic to Brazil nuts also
bound to a transgenic-soybean protein that migrated
with the 2S albumin and that was absent from nontransgenic-soybean extract (Fig. 2B). Serum from two of these
subjects showed very weak binding to proteins in nontransgenic soybeans, but these proteins did not migrate
with the 2S albumin. No binding was observed with seTable 1. Results of Skin-Prick Tests in Three Subjects Allergic to
Brazil Nuts.
SUBJECT
NO.

MAXIMAL WHEAL DIAMETER/MAXIMAL FLARE DIAMETER (mm)
NON TRANSGENIC -

1
2
3

TRANSGENIC -

SOYBEAN

SOYBEAN

BRAZIL - NUT

EXTRACT *

EXTRACT *

DILUENT

HISTAMINE

EXTRACT

0/0
1/0
0/0

6/10
7/19
5/20

2/5
2/0
2/5

15/35 (1:1000)
10/30 (1:1000)
9/29 (1:10,000)
7/26 (1:10,000)
14/41 (1:1,000,000) 8/54 (1:1,000,000)

*The dilutions of the extracts are given in parentheses.

rum from control subjects. IgE from the serum of ﬁve
of the nine subjects allergic to Brazil nuts also bound to
a protein of approximately 12 kd that was present in
some transgenic-soybean extracts (Fig. 2C). The two
bands seen in lane 1 of Figure 2C are most likely the 12kd protein intermediate and the mature 9-kd subunit of
the 2S albumin.8
In addition to the 2S albumin, the transgenic soybean
contained proteins encoded by two bacterial marker
genes: neomycin phosphotransferase and b-glucuronidase.
Puriﬁed commercial preparations of neomycin phosphotransferase and b -glucuronidase denatured with sodium
dodecyl sulfate did not bind IgE from the serum of subjects allergic to Brazil nuts. IgE from the serum of six
of these nine subjects bound to other Brazil-nut proteins.
The identities of these other proteins are not known. In
one case, IgE did not bind detectably to the 2S albumin
but instead recognized a 42-kd protein (Fig. 2D). In another case, IgE bound to both the 2S albumin and the 42kd protein (data not shown), although the binding to the
2S albumin was much stronger; this subject’s serum also
recognized minor IgE-binding proteins of 21, 25, 39, and
57 kd, with comparatively much weaker binding, in Brazil
nuts. In all other cases, binding to other Brazil-nut proteins was not very strong, and there was no consistent
pattern to these individual responses.
Three subjects with histories of hypersensitivity to
Brazil nuts and no history of hypersensitivity to soy-

The New England Journal of Medicine
Downloaded from nejm.org at UNL on March 25, 2022. For personal use only. No other uses without permission.
Copyright © 1996 Massachusetts Medical Society. All rights reserved.

Vol. 334

No. 11

IDENTIFICATION OF A BRAZIL-NUT ALLERGEN IN TRANSGENIC SOYBEANS

beans underwent skin-prick testing. All three had positive reactions to the transgenic-soybean and Brazil-nut
extracts at dilutions ranging from 1:1,000,000 to 1:1000
(Table 1). A representative reaction is shown in Figure
3. All three had positive responses to the histamine control and no response to the saline diluent and the nontransgenic-soybean extract. Three control subjects had
no reaction to full-strength extracts of Brazil nut, transgenic soybean, and soybean or to saline diluent and had
a positive response to the histamine control.
DISCUSSION
The 2S albumin from the Brazil nut is very likely a
major allergen. Major allergens are proteins that bind
substantially to IgE from more than 50 percent of the
patients with that speciﬁc allergy. In this case, serum
from eight of nine subjects allergic to Brazil nuts recognized the 2S albumin as a major IgE-binding protein
of the Brazil nut, and this protein was by far the strongest IgE-binding protein in seven of the eight subjects.
IgE from these seven subjects also bound to the 2S albumin in transgenic soybeans, which carry the Brazilnut 2S albumin gene. Furthermore, skin-prick tests with
extracts of transgenic soybean were positive in the three
subjects allergic to Brazil nuts who were tested, whereas tests with nontransgenic-soybean extract were negative. Oral challenges would be necessary to conﬁrm the
allergenicity of the 2S albumin; however, they would
pose a risk to this group of subjects, most of whom experience life-threatening symptoms on inadvertent consumption of Brazil nuts.
Recently, Melo et al.23 concluded on the basis of experiments in animals that the 2S albumin from the
Brazil nut was not a major allergen. However, the ability of a protein to induce an IgG1 response in animals
is not always a good indicator of the ability of that protein to induce an IgE response in humans. We consider
that our evidence justiﬁes the designation of the 2S albumin from the Brazil nut as a major Brazil-nut allergen, Ber e1.24 Food derived from new plant varieties, including soybeans, that are likely to contain Ber e1
should be appropriately labeled to alert consumers, in
compliance with FDA policy. Our ﬁndings demonstrate the transfer of a major food allergen during the
development of improved crop varieties through genetic engineering.
We also detected some binding of IgE to other Brazilnut and soybean proteins in tests with serum from one
or more of the subjects who were allergic to Brazil nuts.
Binding to a 12-kd protein from the transgenic soybean
(Fig. 2C) can be explained by the fact that the 2S albumin in Brazil nuts is known to be composed of 9-kd
and 3-kd subunits that are processed from a 17-kd precursor protein by means of a 12-kd intermediate.8 In
transgenic soybeans, this processing is often incomplete, resulting in the accumulation of the 12-kd intermediate (unpublished data). The 42-kd protein from
the Brazil nut was the primary allergen for one of the
nine subjects who were allergic to Brazil nuts. However,
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Diluent
Histamine
Undiluted nontransgenic soybean

Brazil nut
(1:1000)

Transgenic
soybean (1:1000)

Brazil nut
(1:100)
Transgenic
soybean (1:100)

Brazil nut
(1:50)
Transgenic
soybean (1:50)

Figure 3. Reactivity on Skin-Prick Testing to Extracts of Transgenic Soybean, Nontransgenic Soybean, and Brazil Nut in a
Subject Allergic to Brazil Nuts.
The dilutions are given in parentheses.

this allergen is not a major Brazil-nut allergen because
most subjects allergic to Brazil nuts who were tested in
our study did not have IgE speciﬁc for this protein.
With other plant foods, such as peanuts and soybeans,
numerous IgE-binding proteins are detected,20,25 and
the identiﬁcation of the major IgE-binding proteins can
be problematic. In the case of animal foods, such as
shrimp and cod, multiple IgE-binding proteins are detected, but one predominant IgE-binding protein is usually easily identiﬁable.26,27
It is prudent to assess the allergenicity of proteins in
transgenic foods if those proteins have been derived
from sources that are commonly allergenic. The use
of currently available animal models alone to predict
allergenicity in humans does not produce accurate
results. Techniques such as radioallergosorbent tests,
SDS-PAGE with immunoblotting, and skin-prick testing
can identify IgE-binding proteins that are probable allergens in transgenic foods derived from sources known
to be allergenic. This strategy will not be useful in assessing the allergenicity of transgenic foods in which
the allergenicity of the source of donor genetic material
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is unknown. Most current applications in the ﬁeld of
plant biotechnology fall into the latter category.
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of Michigan Medical Center, Division of Cardiology, 3910 Taubman Center, Box 0366, 1500
East Medical Center Drive, Ann Arbor, MI 48109. For details about the size and labeling of
the photographs, the requirements for the legend, and authorship, please contact Dr. Eagle
at 313-936-4819 (phone) or 313-936-5256 (fax), or the New England Journal of Medicine at
images@edit.nejm.org (e-mail).
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